Pacific Biosciences of California, Inc. (PACB) News
Track canonical SquawkNews coverage tagged to PACB, Pacific Biosciences of California, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Why PacBio (PACB) Stock Is Trading Up Today
What Happened? Shares of genomics company Pacific Biosciences of California NASDAQ:PACB jumped 5.8% in the afternoon session after genomics provider Sampled announced a five-year contract worth up to $27.1 million from t
EQUITY | Sep 28, 2026, 08:09 PM UTC
L
UBS cuts Pacific Biosciences price target to $1.35 from $1.50
UBS cut its price target for Pacific Biosciences to $1.35 per share from $1.50, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:18 PM UTC
L
PacBio to participate in Morgan Stanley 24th Global Healthcare conference fireside chat
PacBio said management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 2026.
EQUITY | Sep 03, 2026, 08:07 PM UTC
L
PacBio to Participate in Morgan Stanley Global Healthcare Conference
PacBio will participate in the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Sep 03, 2026, 08:06 PM UTC
L
Pacific Biosciences Lowers FY2026 Sales Guidance from $165.000M-$175.000M to $155.000M-$165.000M vs $166.790M Est
Pacific Biosciences (NASDAQ: PACB ) lowers FY2026 sales outlook from $165.000 million-$175.000 million to $155.000 million-$165.000 million vs $166.790 million estimate.
EARNINGS | Aug 05, 2026, 08:29 PM UTC
M
PacBio Appoints Mark Van Oene CEO
PacBio appoints new CEO
EQUITY | Aug 05, 2026, 08:08 PM UTC
M
PacBio Upgrades Vega System
PacBio upgrades Vega system with faster runs
EQUITY | Aug 05, 2026, 01:05 PM UTC